This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) shed 3.25% to $639.37 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 3.56% to 4,146.87 and Dow Jones Industrial Average falling 3.12% to 32,997.97. The stock's fall snapped a two-day winning streak. Regeneron Pharmaceuticals Inc. closed $108.05 below its 52-week high ($747.42), which the company achieved on April 8th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 1.91% to $176.76, Novartis AG ADR (NOVN.EB) fell 2.33% to $86.21, and Amgen Inc. (AMGN) fell 0.74% to $234.35. Trading volume (754,116) eclipsed its 50-day average volume of 645,449.
Data source: Dow Jones Market Data, FactSet. Data compiled May 5, 2022.
(END) Dow Jones Newswires
May 05, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.